We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights Immunocore Holdings, Franklin Covey, Ardmore Shipping, StoneX and Alliance Resource
Read MoreHide Full Article
For Immediate Release
Chicago, IL – July 28, 2022 – Stocks in this week’s article are Immunocore Holdings plc (IMCR - Free Report) , Franklin Covey Co. (FC - Free Report) , Ardmore Shipping Corp. (ASC - Free Report) , StoneX Group Inc. (SNEX - Free Report) , and Alliance Resource Partners, L.P. (ARLP - Free Report) .
5 Stocks With Recent Price Strength to Gain From July Rally
Wall Street has been witnessing a welcome rally in July after reeling under severe volatility in the first half of 2022. This is happening despite the fact that the consumer price index (CPI) soared to its 41-year high in June and a section of economists and financial experts warned that the Fed may hike the benchmark lending rate by 1% in the July FOMC.
Year to date, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — have tumbled 12.6%, 17.7% and 26.1%, respectively. From their all-time highs, these indexes have tanked 14%, 18.3% and 28.7%, respectively.
However, month to date, the Dow, the S&P 500 and the Nasdaq Composite have gained 3.2%, 3.6% and 4.8%, respectively. From their 52-week lows recorded on Jun 16 or Jun 17, the Dow, the S&P 500 and the Nasdaq Composite have rallied 7.1%, 7.8% and 9.4%, respectively. By any means, these are substantial recoveries.
In line with the July rally, a handful of stocks have also shown price strength. These stocks are likely to gain in the near term buoyed by a favorable Zacks Rank. Five of them are — Immunocore Holdings plc, Franklin Covey Co., Ardmore Shipping Corp., StoneX Group Inc., and Alliance Resource Partners, L.P.
Here’s How We Arrived at the Picks
We have primarily targeted stocks that have freshly been on a bull run. Stocks seeing price strength recently have a high chance of carrying the momentum forward.
If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.
However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.
Here’s how you should create the screen to shortlist the current as well as the potential winners.
Just these few criteria narrowed down the search from over 7,700 stocks to a mere seven.
Let’s discuss five out of these seven stocks:
Immunocore is a late-stage biotechnology company. IMCR is engaged in the development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease.
The stock price of Immunocore has jumped 33% in the past four weeks. IMCR has an expected earnings growth rate of 34.1% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.7% over the last 30 days.
Franklin Covey is an international learning and performance solutions company dedicated to increasing the effectiveness of individuals and organizations. FC provides consulting services, training and education programs, educational materials, publications, assessment and measurement tools, implementation processes, application tools and products designed to empower individuals and organizations to become more effective.
The stock price of Franklin Covey has climbed 30.2% in the past four weeks. FC has an expected earnings growth rate of 26% for the current year (ending August 2022). The Zacks Consensus Estimate for current-year earnings has improved 39.1% over the last 30 days.
Alliance Resource is a diversified producer and marketer of coal to major U.S. utilities and industrial users. ARLP currently operate mining complexes in Illinois, Indiana, Kentucky and Maryland. Some of its mining complexes are underground and one has both surface and underground mines.
Alliance Resource produces a diverse range of steam coals with varying sulfur and heat contents, which enable them to satisfy the broad range of specifications demanded by their customers.
The stock price of ARLP has appreciated 15.4% in the past four weeks. Alliance Resource has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.6% over the last 30 days.
Ardmore Shipping is engaged in the ownership and operation of product and chemical tankers. ASC provides shipping services to customers through voyage charters, commercial pools, and time charters.
Ardmore Shipping provides seaborne transportation of petroleum products and chemicals worldwide to oil majors, national oil companies, oil and chemical traders, and chemical companies.
The stock price of ASC has surged 14.4% in the past four weeks. Ardmore Shipping has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved more than 100% over the last 30 days.
StoneX operates as a global financial services network that connects companies, organizations, traders, and investors to the market ecosystem worldwide. SNEX’s Institutional segment provides equity trading services to institutional clients; and originates, structures, and places debt instruments in capital markets worldwide.
StoneX’s Commercial segment provides risk management and hedging, exchange-traded and OTC products execution and clearing, voice brokerage, market intelligence, physical trading, and commodity financing and logistics services.
The stock price of SNEX has advanced 11.2% in the past four weeks. StoneX has an expected earnings growth rate of 37.4% for the current year (ending September 2022). The Zacks Consensus Estimate for current-year earnings has improved 6.2% over the last 30 days.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks.com featured highlights Immunocore Holdings, Franklin Covey, Ardmore Shipping, StoneX and Alliance Resource
For Immediate Release
Chicago, IL – July 28, 2022 – Stocks in this week’s article are Immunocore Holdings plc (IMCR - Free Report) , Franklin Covey Co. (FC - Free Report) , Ardmore Shipping Corp. (ASC - Free Report) , StoneX Group Inc. (SNEX - Free Report) , and Alliance Resource Partners, L.P. (ARLP - Free Report) .
5 Stocks With Recent Price Strength to Gain From July Rally
Wall Street has been witnessing a welcome rally in July after reeling under severe volatility in the first half of 2022. This is happening despite the fact that the consumer price index (CPI) soared to its 41-year high in June and a section of economists and financial experts warned that the Fed may hike the benchmark lending rate by 1% in the July FOMC.
Year to date, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — have tumbled 12.6%, 17.7% and 26.1%, respectively. From their all-time highs, these indexes have tanked 14%, 18.3% and 28.7%, respectively.
However, month to date, the Dow, the S&P 500 and the Nasdaq Composite have gained 3.2%, 3.6% and 4.8%, respectively. From their 52-week lows recorded on Jun 16 or Jun 17, the Dow, the S&P 500 and the Nasdaq Composite have rallied 7.1%, 7.8% and 9.4%, respectively. By any means, these are substantial recoveries.
In line with the July rally, a handful of stocks have also shown price strength. These stocks are likely to gain in the near term buoyed by a favorable Zacks Rank. Five of them are — Immunocore Holdings plc, Franklin Covey Co., Ardmore Shipping Corp., StoneX Group Inc., and Alliance Resource Partners, L.P.
Here’s How We Arrived at the Picks
We have primarily targeted stocks that have freshly been on a bull run. Stocks seeing price strength recently have a high chance of carrying the momentum forward.
If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.
However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.
Here’s how you should create the screen to shortlist the current as well as the potential winners.
Just these few criteria narrowed down the search from over 7,700 stocks to a mere seven.
Let’s discuss five out of these seven stocks:
Immunocore is a late-stage biotechnology company. IMCR is engaged in the development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease.
The stock price of Immunocore has jumped 33% in the past four weeks. IMCR has an expected earnings growth rate of 34.1% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.7% over the last 30 days.
Franklin Covey is an international learning and performance solutions company dedicated to increasing the effectiveness of individuals and organizations. FC provides consulting services, training and education programs, educational materials, publications, assessment and measurement tools, implementation processes, application tools and products designed to empower individuals and organizations to become more effective.
The stock price of Franklin Covey has climbed 30.2% in the past four weeks. FC has an expected earnings growth rate of 26% for the current year (ending August 2022). The Zacks Consensus Estimate for current-year earnings has improved 39.1% over the last 30 days.
Alliance Resource is a diversified producer and marketer of coal to major U.S. utilities and industrial users. ARLP currently operate mining complexes in Illinois, Indiana, Kentucky and Maryland. Some of its mining complexes are underground and one has both surface and underground mines.
Alliance Resource produces a diverse range of steam coals with varying sulfur and heat contents, which enable them to satisfy the broad range of specifications demanded by their customers.
The stock price of ARLP has appreciated 15.4% in the past four weeks. Alliance Resource has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.6% over the last 30 days.
Ardmore Shipping is engaged in the ownership and operation of product and chemical tankers. ASC provides shipping services to customers through voyage charters, commercial pools, and time charters.
Ardmore Shipping provides seaborne transportation of petroleum products and chemicals worldwide to oil majors, national oil companies, oil and chemical traders, and chemical companies.
The stock price of ASC has surged 14.4% in the past four weeks. Ardmore Shipping has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved more than 100% over the last 30 days.
StoneX operates as a global financial services network that connects companies, organizations, traders, and investors to the market ecosystem worldwide. SNEX’s Institutional segment provides equity trading services to institutional clients; and originates, structures, and places debt instruments in capital markets worldwide.
StoneX’s Commercial segment provides risk management and hedging, exchange-traded and OTC products execution and clearing, voice brokerage, market intelligence, physical trading, and commodity financing and logistics services.
The stock price of SNEX has advanced 11.2% in the past four weeks. StoneX has an expected earnings growth rate of 37.4% for the current year (ending September 2022). The Zacks Consensus Estimate for current-year earnings has improved 6.2% over the last 30 days.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/1958425/5-stocks-with-recent-price-strength-to-gain-from-july-rally
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.